2018年 · 第56卷第01期

At the end of the year and the beginning of spring, everything is renewed, and the curtain of a new era has slowly opened. As an advanced academic journal of surgery sponsored by the Chinese Medical Association, Chinese Journal of Surgery, with the support of many editorial board members and surgeons, has always adhered to the good original intention at the beginning of its publication, and played an important role in reporting, communication, continuing education, talent education and guidance. With the continuous development of surgical technology, the continuous optimization and improvement of surgical methods and surgical instruments, the output of scientific papers in China is booming unprecedentedly. As editors and authors of academic journals in the new period, we should deepen and strengthen the journal work from all aspects in combination with the strategic positioning of the society put forward in the five-year work plan of the 25th Council of Chinese Medical Association, which is guided by the strategy of "Party building and strengthening the society", supported by the strategy of "quality strengthening the society" and the strategy of "collaborative innovation".

With the popularization of abdominal imaging, the detection rate of pancreatic cystic neoplasm (PCN) is increasing year by year^[1]。 According to statistics, at least 1% of hospitalized patients have pancreatic cystic lesions, and about 10% of people>70 years old have pancreatic cystic lesions, of which more than 60% are PCN^[2]。 PCN is a complex disease with many types, including intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm (MCN), serous cystic neoplasm (SCN), solid pseudo-papillary tumor (SPT), cystic neuroendocrine tumor, ductal adenocarcinoma cystic degeneration, acinar cell cystic tumor, etc.^[1,3]。 The lesion nature of PCN involves benign, borderline, and malignant^[4]； The development process is relatively long, and timely treatment is needed for PCN with malignant potential^[5]。

The adjustment will allow a single supervisor or a new senior supervisor to manage doctors and nurses, replacing the current nine-member supervisory team comprising doctors, dentists, nurses, pharmacists and other medical professionals.